Charalampia Kyriakou

Summary

Country: UK

Publications

  1. doi request reprint High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
    Charalampia Kyriakou
    University College London, 4 Sentis Court, 8 Carew Rd, Northwood, Middlesex, United Kingdom
    J Clin Oncol 26:218-24. 2008
  2. doi request reprint High-dose therapy and autologous stem-cell transplantation in Waldenstrom macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
    Charalampia Kyriakou
    North West London, NHS Trust, Watford Rd, Harrow, Middlessex, HA1 3UJ, United Kingdom
    J Clin Oncol 28:2227-32. 2010
  3. doi request reprint Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
    Charalampia Kyriakou
    North West London National Health Services Trust, Harrow, Middlessex, United Kingdom
    J Clin Oncol 28:4926-34. 2010

Detail Information

Publications3

  1. doi request reprint High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
    Charalampia Kyriakou
    University College London, 4 Sentis Court, 8 Carew Rd, Northwood, Middlesex, United Kingdom
    J Clin Oncol 26:218-24. 2008
    ..The aim of this study was to evaluate the effect of high-dose therapy (HDT) followed by autologous stem-cell transplantation (ASCT) on patients with AITL...
  2. doi request reprint High-dose therapy and autologous stem-cell transplantation in Waldenstrom macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
    Charalampia Kyriakou
    North West London, NHS Trust, Watford Rd, Harrow, Middlessex, HA1 3UJ, United Kingdom
    J Clin Oncol 28:2227-32. 2010
    ..The aim of this study was to analyze the results of ASCT in patients with WM and to determine the prognostic factors that have a significant impact on outcome...
  3. doi request reprint Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
    Charalampia Kyriakou
    North West London National Health Services Trust, Harrow, Middlessex, United Kingdom
    J Clin Oncol 28:4926-34. 2010
    ..Information regarding alloSCT in Waldenström macroglobulinemia (WM) is limited. This study presents the long-term outcome of a large series of patients with WM treated with alloSCT...